LSB

LakeShore Biopharma

14 hedge funds and large institutions have $20.4M invested in LakeShore Biopharma in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
14
Holders Change
+14
Holders Change %
% of All Funds
0.22%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
14
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
O
1
OrbiMed
New York
$6.88M 4,298,464 +4,298,464 New
Fidelity International
2
Fidelity International
Bermuda
$4.35M 2,718,499 +2,718,499 New
SLM
3
Snow Lake Management
California
$2.9M 1,811,942 +1,811,942 New
VAM
4
Valliance Asset Management
Hong Kong
$2.57M 1,607,175 +1,607,175 New
Fidelity Investments
5
Fidelity Investments
Massachusetts
$1.86M 1,165,071 +1,165,071 New
HA
6
HHLR Advisors
Cayman Islands
$1.2M 751,790 +751,790 New
RI
7
RTW Investments
New York
$546K 341,090 +341,090 New
Millennium Management
8
Millennium Management
New York
$37K 23,086 +23,086 New
FSI
9
Flow State Investments
Illinois
$32K 20,000 +20,000 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$21.8K 13,608 +13,608 New
Jane Street
11
Jane Street
New York
$19.2K 11,971 +11,971 New
PAM
12
Pinpoint Asset Management
Hong Kong
$7.79K 50,000 +50,000 New
WAM
13
Wolverine Asset Management
Illinois
$798 499 +499 New
CS
14
Clear Street
New York
$160 100 +100 New